Search Blog
Categories
June 2017
M T W T F S S
« May    
 1234
567891011
12131415161718
19202122232425
2627282930  

Tags

IIROC Trade Resumption – Belo Sun Mining Corp.

Toronto, Ontario–(Newsfile Corp. – June 22, 2017) – Trading resumes in:

Company:

Belo Sun Mining Corp.

TSX Symbol:

BSX (all issues)

Resumption Time (ET):

16:15

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

IIROC Trade Resumption – Cobalt 27 Capital Corp.

Vancouver, British Columbia–(Newsfile Corp. – June 22, 2017) – Trading resumes in:

Company:

Cobalt 27 Capital Corp.

TSX-V Symbol:

KBLT

Resumption Time (ET):

08:00 June 23, 2017

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

IIROC Trade Resumption – Percy Street Capital Corporation

Vancouver, British Columbia–(Newsfile Corp. – June 22, 2017) – Trading resumes in:

Company:

Percy Street Capital Corporation

TSX-V Symbol:

PSC.P

Resumption Time (ET):

08:00 June 23, 2017

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

IIROC Trade Halt – Dream Office Real Estate Investment Trust

Toronto, Ontario–(Newsfile Corp. – June 22, 2017) – The following issues have been halted by IIROC:

Company:

Dream Office Real Estate Investment Trust

TSX Symbol:

D.UN (all issues)

Reason:

Pending News

Halt Time (ET)

16:00

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

DS Healthcare Group Announces FINRA Update

By DS Healthcare Group, Inc.

POMPANO BEACH, FL / ACCESSWIRE / June 22, 2017 / DS Healthcare Group (OTC PINK: DSKX) today announced that FINRA has informed Windsor Street Capital LP, a market maker, that it has approved its common stock for price quotation on the OTC Market Group’s OTC Link quotation system. Windsor Street Capital LP is facilitating the process to have price quotations on OTC Link.

About DS Healthcare Group

DS Healthcare Group Inc. is a leader in the development of biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, and pharmacies. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group’s flagship brand, visit www.dslaboratories.com.

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies, and are generally preceded by words such as “future,” “plan,” or “planned,” “expects,” or “projected.” These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company’s control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.

SOURCE: DS Healthcare Group

ReleaseID: 466576

IIROC Trade Resumption – Postmedia Network Canada Corp.

Toronto, Ontario–(Newsfile Corp. – June 22, 2017) – Trading resumes in:

Company:

Postmedia Network Canada Corp.

TSX Symbol:

PNC.B (all issues)

Resumption Time (ET):

15:00

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

IIROC Trade Halt – Belo Sun Mining Corp.

Toronto, Ontario–(Newsfile Corp. – June 22, 2017) – The following issues have been halted by IIROC:

Company:

Belo Sun Mining Corp.

TSX Symbol:

BSX (all issues)

Reason:

Pending News

Halt Time (ET)

15:14

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

Black Birch Capital Acquisition III Corp. Announces Closing of First Tranche of Non-Brokered Private Placement of $328,164

Black Birch Capital Acquisition III Corp. Announces Closing of First Tranche of Non-Brokered Private Placement of $328,164

TORONTO, ONTARIO (FSCwire) – Black Birch Capital Acquisition III Corp. (NEX: BBC.H) (the “Company”), further to the news releases of May 10, 2017 announced today that it has closed the first tranche of a non-brokered private placement by issuing 6,563,280 common shares, at a price of $0.05 per share, for gross proceeds to the Company of $328,164 (the “Offering”). No warrants were issued. No finder’s fee was paid in connection with the closing of the Offering.

The Offering is subject to approval of the NEX Board of the TSX Venture Exchange (the “NEX”). All common shares issued in connection with the Offering are subject to a 4 month hold period expiring on October 21, 2017. Proceeds from the Offering shall be used for investigating project acquisitions and general corporate purposes.

On behalf of the Board of Directors

Black Birch Capital Acquisition III Corp.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO SELL ANY OF THE SECURITIES DESCRIBED HEREIN IN THE UNITED STATES. THESE SECURITIES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE UNITED STATED SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

To view this press release as a PDF file, click onto the following link:

Maximum News Dissemination by FSCwire. http://www.fscwire.com

Copyright © 2017 Filing Services Canada Inc.

INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Neurotrope, Inc. and Reminds Investors with Losses to Contact the Firm

By Khang & Khang LLP

IRVINE, CA / ACCESSWIRE / June 22, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Neurotrope, Inc. (“Neurotrope” or the “Company”) (NASDAQ: NTRP). Investors, who purchased or otherwise acquired Neurotrope shares from January 7, 2016 through April 28, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the July 17, 2017 lead plaintiff motion deadline.

If you purchased Neurotrope shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may also choose to take no action and remain a passive class member.

According to the Complaint, throughout the Class Period, Neurotrope made false and/or misleading statements and/or failed to disclose material adverse information about the efficacy of its lead product candidate, Bryostatin-1. On May 1, 2017, the Company announced “positive top-line results” of the focal Phase 2b trials of Bryostatin-1, mentioning “improvement in patients with moderate to severe Alzheimer’s disease.” The trial data negates these statements, however, as the top-line data relating to the 20-microgram dose of Bryostatin-1 did not produce statistically significant results. Neurotrope also allegedly failed to disclose statements about the efficacy of the 40-microgram dose in connection with its primary and secondary endpoints. After release of this news, the stock price of Neurotrope fell materially, which harmed investors according to the Complaint.

If you wish to learn more about this lawsuit, or if you have questions about this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may be considered Attorney Advertising in certain jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 466572

APPROACHING DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Vince Holding Corp. and Reminds Investors with Losses to Contact the Firm

By Khang & Khang LLP

IRVINE, CA / ACCESSWIRE / June 22, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Vince Holding Corp. (“Vince” or the “Company”) (NYSE: VNCE). Investors, who purchased or otherwise acquired Vince shares between December 8, 2016 and April 27, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the July 5, 2017 lead plaintiff motion deadline.

If you purchased Vince shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, during the Class Period, Vince made false and/or misleading statements and/or failed to disclose that during the transition from legacy Kellwood systems, the Company experienced issues related to integrating its new enterprise resource planning systems; and thus, Vince’s statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. Upon release of this information to the public, the Company’s stock price dropped materially, which harmed investors according to the Complaint.

If you wish to learn more about this lawsuit, or if you have questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may be considered Attorney Advertising in certain jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 466573